SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the introduction of the NanoDis System for nanoparticle dissolution testing. Combining Agilent instrumentation ...
In the manufacture of solid dosage forms, the rate at which the active pharmaceutical ingredient (API) is dissolved into solvents simulating the digestive tract fluids is determined with dissolution ...
In order to highlight the importance of dissolution testing in pharmaceutical industry as a tool in drug development and quality control, Society for Pharmaceutical Dissolution Science (SPDS) ...
Agilent Technologies Inc., a global leader in life sciences, diagnostics, and applied chemical markets, announced the introduction of the NanoDis System for nanoparticle dissolution testing. Combining ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results